Efficacy and comfort of olopatadine 0.2% versus epinastine 0.05% ophthalmic solution for treating itching and redness induced by conjunctival allergen challenge

By Mah Francis S.   Rosenwasser Lanny J.   Townsend William D.   Greiner Jack V.   Bensch George  

Current Medical Research and Opinion, Vol. 23, Iss. 6, 2007-06 ,pp. : 1445-1452

Informa Healthcare

Access to resources Recommend Favorite

Evaluation of the effects of olopatadine ophthalmic solution, 0.2% on the ocular surface of patients with allergic conjunctivitis and dry eye

By Mah F. S.   O'Brien T.   Kim T.   Torkildsen G.  

Current Medical Research and Opinion, Vol. 24, Iss. 2, 2008-02 ,pp. : 441-447

Informa Healthcare

Access to resources Recommend Favorite

Phase III efficacy and safety study of besifloxacin ophthalmic suspension 0.6% in the treatment of bacterial conjunctivitis

By Tepedino Michael E.   Heller Warren H.   Usner Dale W.   Brunner Lynne S.   Morris Timothy W.   Haas Wolfgang   Paterno Michael R.   Comstock Timothy L.  

Current Medical Research and Opinion, Vol. 25, Iss. 5, 2009-05 ,pp. : 1159-1169

Informa Healthcare

Access to resources Recommend Favorite

Effects of a new formulation of olopatadine ophthalmic solution on nasal symptoms relative to placebo in two studies involving subjects with allergic conjunctivitis or rhinoconjunctivitis

By Abelson Mark B.   Gomes Paul J.   Vogelson Cullen T.   Pasquine Terri A.   Turner F. Darell   Wells David T.   Robertson Stella M.  

Current Medical Research and Opinion, Vol. 21, Iss. 5, 2005-05 ,pp. : 683-692

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and safety of rupatadine for allergic rhino-conjunctivitis: a systematic review of randomized, double-blind, placebo-controlled studies with meta-analysis

By Compalati Enrico   Canonica Giorgio Walter  

Current Medical Research and Opinion, Vol. 29, Iss. 11, 2013-11 ,pp. : 1539-1551

Informa Healthcare

Access to resources Recommend Favorite